
USFDA APPLICATION NUMBER - 204168 / DOSAGE - CAPSULE, EXTENDED RELEASE;ORAL - EQ 80MG BASE
| Active Ingredient/Active Moiety | ||
| Ingredient Name | Basis of Strength | Strength |
|---|---|---|
| LEVOMILNACIPRAN HYDROCHLORIDE(UNII: 371U2ZK31U) (levomilnacipran - UNII:UGM0326TXX) | levomilnacipran | 40mg |
Inactive Ingredients
| Ingredient Name | Avera McKennan Hospital |
|---|---|
| ethylcelluloses(7Z8S9VYZ4B) | |
| FERRIC OXIDE YELLOW(EX438O2MRT) | |
| FERROSOFERRIC OXIDE(XM0M87F357) | |
| hypromelloses(3NXW29V3WO) | |
| povidone(FZ989GH94E) | |
| shellac(46N107B71O) | |
| SUCROSE(C151H8M554) | |
| talc(7SEV7J4R1U) | |
| titanium dioxide(15FIX9V2JP) | |
| triethyl citrate(8Z96QXD6UM) |